Literature DB >> 10721496

The comorbidity of depression and substance use disorders.

J D Swendsen1, K R Merikangas.   

Abstract

Depression and substance use disorders are highly prevalent in the general population and often co-occur within the same individual. This association is most commonly explained either by a causal relationship or a shared etiologic factor underlying both disorders. In light of these mechanisms of association, this article summarizes evidence from clinical, epidemiologic, and genetic epidemiologic studies. Details of a large family study designed to addresses key methodological and conceptual issues identified in the review are also presented. The association of alcoholism with depression is likely to be attributable to causal factors rather than a shared etiology, but the scarcity of information for other classes of substance use disorders precludes similar conclusions regarding their association with depression. The lack of unidirectional and consistent patterns of association for depression and substance use disorders indicates that multiple mechanisms of comorbidity are likely to be simultaneously active in this population.

Entities:  

Mesh:

Year:  2000        PMID: 10721496     DOI: 10.1016/s0272-7358(99)00026-4

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  157 in total

1.  Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Analucía A Alegría; Deborah S Hasin; Edward V Nunes; Shang-Min Liu; Carrie Davies; Bridget F Grant; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Traumatic stress and the mediating role of alcohol use on HIV-related sexual risk behavior: results from a longitudinal cohort of South African women who attend alcohol-serving venues.

Authors:  Laurie Abler; Kathleen J Sikkema; Melissa H Watt; Eileen V Pitpitan; Seth C Kalichman; Donald Skinner; Desiree Pieterse
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

3.  Agitated depression in substance dependence.

Authors:  Adam M Leventhal; Joel Gelernter; David Oslin; Raymond F Anton; Lindsay A Farrer; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2011-01-31       Impact factor: 4.492

4.  Affect and peer context interactively impact adolescent substance use.

Authors:  Andrea M Hussong; Richard E Hicks
Journal:  J Abnorm Child Psychol       Date:  2003-08

5.  Prevalence and predictors of risky and heavy alcohol consumption among adult siblings of childhood cancer survivors.

Authors:  E Anne Lown; Ann C Mertens; Rachael A Korcha; Wendy Leisenring; Melissa M Hudson; Thomas K Greenfield; Leslie L Robison; Lonnie K Zeltzer
Journal:  Psychooncology       Date:  2012-06-27       Impact factor: 3.894

6.  Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006.

Authors:  Young-Hee Yoon; Chiung M Chen; Hsiao-Ye Yi; Howard B Moss
Journal:  Compr Psychiatry       Date:  2010-12-13       Impact factor: 3.735

7.  Clinical implications of drug abuse epidemiology.

Authors:  Jeffrey D Schulden; Marsha F Lopez; Wilson M Compton
Journal:  Psychiatr Clin North Am       Date:  2012-06

8.  Co-occurring psychiatric and drug use disorders among sexual minority men with lifetime alcohol use disorders.

Authors:  Ji Hyun Lee; Kristi E Gamarel; Christopher W Kahler; Brandon D L Marshall; Jacob J van den Berg; Kendall Bryant; Nickolas D Zaller; Don Operario
Journal:  Drug Alcohol Depend       Date:  2015-03-30       Impact factor: 4.492

9.  Childhood depressive symptoms and early onset of alcohol use.

Authors:  Ping Wu; Hector R Bird; Xinhua Liu; Bin Fan; Cordelia Fuller; Sa Shen; Cristiane S Duarte; Glorisa J Canino
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

10.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.